The global umbrella organisation for liver patient organisations, with patients always at the centre.
Founded in 2019, Liver Patients International (LPI) supports and advocates for liver patients in both policy and operational contexts, promoting equal access to effective liver healthcare services. We do that together with our members, over 15 patient organisations, and all stakeholders (scientific organisations, advocacy groups, pharmaceutical companies, and other related organisations).
We welcome all organisations as members or stakeholder who want to make a difference for all that they support.
The global umbrella organisation for liver patient organisations, with patients always at the centre.
Founded in 2019, Liver Patients International (LPI) supports and advocates for liver patients in both policy and operational contexts, promoting equal access to effective liver healthcare services. We do that together with our members, over 15 patient organisations, and all stakeholders (scientific organisations, advocacy groups, pharmaceutical companies, and other related organisations).
We welcome all organisations as members or stakeholder who want to make a difference for all that they support.
The global umbrella organisation for liver patient organisations, with patients always at the centre.
Founded in 2019, Liver Patients International (LPI) supports and advocates for liver patients in both policy and operational contexts, promoting equal access to effective liver healthcare services. We do that together with our members, over 15 patient organisations, and all stakeholders (scientific organisations, advocacy groups, pharmaceutical companies, and other related organisations).
We welcome all organisations as members or stakeholder who want to make a difference for all that they support.
Who we are
With a growing membership of more than 15 established liver patient organisations worldwide, from South America and Africa to Europe. LPI is overseen by a managing board whose members are each experienced representatives of patients’ organisations. Together, they bring expertise across a full range of liver diseases, organisational management, and governance.
What we do
We undertake activities to improve care and treatment for people affected by or at risk of a liver condition. We work in a progressive and collaborative way, ensuring meaningful engagement and partnerships with other stakeholders. We strengthen the (member) patient organisations’ guidance in policy, advocacy, and cooperation with stakeholders to reach the goal together. We participate in projects, scientific (EU) research programmes, and are involved in many policy and advocacy groups. We do that with expertise from all our members and stakeholders, through cooperation, information sharing, and mutual support.
Become a member or stakeholder
Together, we will be able to support, develop, and lead efforts to increase patient support and advocacy, playing a crucial role in shaping global health policy and strategies through partnerships.
We are open to registered NGOs and charitable organisations, regardless of size, that work in the field of liver disease.
But we also reach out to scientific, advocacy, and policy organisations, as well as pharmaceutical companies. LPI is open to strong collaboration with organisations that are not necessarily liver patient organisations but share our goals and ideals.
Membership is free of charge.
Our news
HepC : a brochure for patients
LPI, in a collaboration with HEPACTIVE Association_Bulgaria, is launching an...
CDC: What to Know About Liver Disease and COVID-19
According to CDC - CENTERS FOR DISEASE CONTROL AND PREVENTION Coronavirus...
LPI’s Patients’ stories: Living with Hepatic Encephalopathy (HE)_Fam Pieterse
Mr Wim Pieters passed away in November 2020. His family considers the...
Press Release LPI 2021
01/05/2021: PRESS RELEASE Launch of new International liver patients...
Our Network: ACHIEVE updates on EU4Health Program 2021-2027
The European Council and the European Parliament have reached a provisional...
Wilton Park virtual dialogue: Consensus for Care Pathways for NAFLD/NASH
The report from Wilton Park's virtual dialogue Consensus for Care Pathways...
AWARH: 8th Awareness Week on Alcohol related Harm
The 8th Awareness Week on Alcohol related Harm will be held from 16th to 20th...
European Testing Week
#EuroTestWeek 20-27th November, SAVE THE DATE! As the pandemic of Covid-19...
3 win Nobel medicine prize for discovering hepatitis C virus
5th October 2020 : Three scientists - British scientist Michael Houghton and...
#OctoberIs4Livers_GLI
Global Liver Institute (GLI) always devoted to saving lives from liver cancer,...
















